| 000 | 01747 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250513032953.0 | ||
| 264 | 0 | _c19951127 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBowden, R A | |
| 245 | 0 | 0 |
_aA comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. _h[electronic resource] |
| 260 |
_bBlood _cNov 1995 |
||
| 300 |
_a3598-603 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aBlood Banks _xstandards |
| 650 | 0 | 4 |
_aBlood Transfusion _xmethods |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xmortality |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFiltration |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukocytes _xvirology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMass Screening _xstandards |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransfusion Reaction |
| 700 | 1 | _aSlichter, S J | |
| 700 | 1 | _aSayers, M | |
| 700 | 1 | _aWeisdorf, D | |
| 700 | 1 | _aCays, M | |
| 700 | 1 | _aSchoch, G | |
| 700 | 1 | _aBanaji, M | |
| 700 | 1 | _aHaake, R | |
| 700 | 1 | _aWelk, K | |
| 700 | 1 | _aFisher, L | |
| 700 | 1 | _aMcCullough, J | |
| 700 | 1 | _aMiller, W | |
| 773 | 0 |
_tBlood _gvol. 86 _gno. 9 _gp. 3598-603 |
|
| 999 |
_c7578924 _d7578924 |
||